Press Releases

Virus-like Particles (VLPs) for Various Applications Now Available at Creative Biostructure

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module. The IGX Platform is a professional tool to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger and NGS data and independently perform complex analyses.

Scytek Laboratories Inc Stain Nuclei Histology Red Special Stain,Histology,Nuclear Fast Red Solution,H E,Eosin

Scytek laboratories Inc offers Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn, Scytek Stain Nuclei Histology Red Special Stain, Histology, Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system

Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.

THREAD and 1nHealth Partner to Optimize Participant Recruitment in Decentralized Clinical Trials

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

eClinical Solutions Launches elluminate® Clinical Trial Management System (CTMS) for Faster Drug Development

The elluminate platform now automates clinical operations data workflows with focus on interoperability and analytics for outsourced development models

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., the world leader in recombinant human albumin, has entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen

BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments

Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market

Alfa Chemistry Recently Launched a Sub-website for Functional Polymers

Syntekabio and Hanmi Science Join Forces to Co-Develop New Promising COVID-19 Treatments Using Drug Repurposing Technologies

Syntekabio has announced a strategic collaboration with Hanmi Science to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.

Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases

Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.

CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.

Alfa Chemistry Launches MOF Chemicals for the Science Community

MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development

To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.

Alfa Chemistry Provides Wide Choices of Pyridinium Ionic Liquids for Scientific Research

Pyridinium ionic liquids are widely applied in Diels-Alder reaction, Friedel-Crafts reaction, Suzuki reaction, Grignard Reaction as well as the synthesis of some pharmaceutical agents. To meet the growing needs for this type of chemicals, Alfa Chemistry recently announced to provide wide choices of pyridinium ionic liquids for clients both at home and abroad. Most of them are in stock and can be delivered to buyers within a few business days.

eNUVIO is Launching the OMEGA-96 Device

Today, eNUVIO has announced the launch of their latest innovative microfluidic device for neuronal compartmentalization and co-culture experiments — the OMEGA-96. This first of its kind microplate will help to improve the success and efficiency of drug discovery and safety toxicology in neurological research areas, particularly in the field of neurodegenerative and neuromuscular diseases.

Parent Project Muscular Dystrophy’s Duchenne Registry Participant Response Rate Increases Exponentially in 2020 Utilizing THREAD

Year one of The Duchenne Registry powered by THREAD’s decentralized platform sees uptick in survey completion, data collection, and community engagement

Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies

These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.